IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 161 filers reported holding IMPAX LABORATORIES INC in Q3 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $12,428,000 | +317.5% | 612,236 | +172.4% | 0.85% | +312.7% |
| Q4 2016 | $2,977,000 | +204.4% | 224,721 | +589.0% | 0.20% | +210.6% |
| Q2 2014 | $978,000 | +24.3% | 32,616 | +9.4% | 0.07% | +22.2% |
| Q1 2014 | $787,000 | -86.8% | 29,816 | -87.5% | 0.05% | -89.3% |
| Q4 2013 | $5,973,000 | +72.0% | 237,626 | +40.0% | 0.50% | +43.2% |
| Q3 2013 | $3,473,000 | – | 169,681 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 730,817 | $21,062,000 | 7.59% |
| Hound Partners | 6,757,558 | $194,753,000 | 5.18% |
| Aravt Global | 2,232,500 | $64,341,000 | 4.78% |
| Asymmetry Capital Management, L.P. | 70,235 | $2,024,000 | 3.71% |
| UNIVERSITY OF NOTRE DAME DU LAC | 66,091 | $1,905,000 | 1.80% |
| Orbimed Advisors | 5,886,700 | $169,655,000 | 1.77% |
| Pennant Capital Management, LLC | 1,949,569 | $56,187,000 | 1.44% |
| SECTOR GAMMA AS | 233,934 | $6,742,000 | 1.28% |
| Tygh Capital Management, Inc. | 137,190 | $3,954,000 | 1.11% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 555,086 | $15,998,000 | 0.93% |